Info for shareholders
Introductory note
In conformity with the relevant stipulations in the law of May 2, 2007 on the publication of major participations, de Omega Pharma has issued a press release with the most recent update on November 4, 2008. The information included in this press release is also available at this web page under the menu items Shareholder Structure and Share Capital.
The notification thresholds for major participations are set by the Extraordinary Shareholders Meeting of 9 June 2009 at 3%, 5%, 7.5% and multiples of 5%.
Notification forms can be downloaded from http://www.cbfa.be/eng/gv/ah/circ/ah_circ.asp. Shareholders who think they should issue a notification can contact Mr. Chris Van Raemdonck, Investor Relations Officer of Omega Pharma for advice (+32/9/381.0331 - chris.vanraemdonck@omega-pharma.be).
Content
Financial services [top]
Omega Pharma makes an appeal to the following organisations for providing financial services to its shareholders:
The general shareholders meeting of 5 May 2009 has decided to pay-out a gross dividend of EUR 0.60 per share (net EUR 0.50) for the accounting period 2008. As of 11 May 2009 the dividends were payable against exchange of coupon number 12 (code SRW 3785.02) at the counters of ING Bank Belgium, KBC Bank, Fortis Bank, Dexia Bank, Bank Degroof and Petercam.
Dividend history
Here is an overview of the gross dividends per share that have been paid out (the net dividend is mentioned between brackets)
1997 EUR 0.0702 (EUR 0.0526)
1998 EUR 0.1983 (EUR 0.1487)
1999 EUR 0.0330 (EUR 0.0250) After split of the shares 10:1
2000 EUR 0.05 (EUR 0.0375)
2001 EUR 0.09 (EUR 0.06)
2002 EUR 0.12 (EUR 0.09)
2003 EUR 0.18 (EUR 0.135)
2004 EUR 0.24 (EUR 0.18)
2005 EUR 0.32 (EUR 0.24)
2006 EUR 0.40 (EUR 0.30)
2007 EUR 0.50 (EUR 0.375)
2008 EUR 0.60 (EUR 0.50)
|
Situation 4 July 2008* |
Situation 25 March 2008 | |
|---|---|---|
|
Effective voting rights (shares issued) |
24 227 303 |
26 207 968 |
|
Future voting rights (warrants) |
171 305 |
198 479 |
|
Total of effective and future voting rights |
24 398 608 |
26 406 447 |
* cancellation of 2 million bought-back treasury shares by the Extraordinary Shareholders Meeting of 9 June 2008 + elimination of expired warrants until and including 9 July 2008 + exercise of 19,335 warrants on 3 July 2008.
The chart below has been developed on the basis of the effective voting rights (the "denominator") and takes account of the base declarations of shareholdings reflecting the situation on September 1, 2007. The law of May 2, 2007 specifies that such base declarations need to be issued before October 31, 2008.
|
Situation on October 17, 2008 according to the received (base) declarations | |
|---|---|
|
Couckinvest NV/Marc Coucke (base declaration of September 22, 2008) |
30.86% |
|
Treasury shares (base declaration of September 22, 2008) |
3.86% |
| Capital Group International (notification of situation September 24, 2009) |
2.84% |
|
Public |
63.29% |
|
Total |
100.00% |
Based on the above-mentioned base declarations, the entire free float (excluding Couckinvest/Marc Coucke and the treasury shares) thus amounts to 65.28%.
When taking the notification of January 29, 2009 by Couckinvest into account, the shareholder structure is as follows: Couckinvest/Marc Coucke 30.01% - treasury shares 3.86% - free float 66.13%
Article 11 of the articles of association of the company specifies that participations must be notified as soon as a threshold of 3%, 5%, 7.5% and any multiple of 5% has been passed.
(*) On 1 September 2007, Couckinvest NV/Marc Coucke held 30.29% of the shares with voting rights. (Cfr. official notification).
General shareholders meeting [top]
The specifications regarding the general meeting of shareholders are included in the articles 30 until 39 included of the articles of association of the company.
The annual general shareholders meeting takes place at the official company address every first Monday of May, starting at 19.00 CET.
The convocation, the agenda and the proxy form for each general shareholders meeting are published in this web site under the heading Press releases.
In order to participate at a general shareholders meeting, the owners of dematerialized shares should request from the holder of the global account or from the financial intermediary where the shareholder holds his shares, a certificate that confirms that there shares are made unavailable until the time of the general shareholders meeting; they should deposit this certificate at least three working days in advance with an institution that is appointed by the board of directors. Each shareholder can make use of a written proxy to have himself lawfully represented at the general shareholders meeting. Each share gives right to one vote.
For specific questions concerning the participation at a general shareholders meeting, please contact Mrs Sabine Van Coppenolle (sabine.vancoppenolle@omega-pharma.be - tel. 0032/9/381 03 20).
The first coming general shareholders meeting has been scheduled for 4 May 2009.
Codes
Listing
Key figures egarding the share in 2008 [top]
On 31 December 2008, the share capital amounted to EUR 16,464,661.41- represented by 24 227 303 shares.
Stock exchange data